Future Medicine Co., Ltd. (XKON:341170)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,670.00
+71.00 (4.44%)
At close: Feb 13, 2026

Future Medicine Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2021FY 2020FY 2019
Period Ending
Feb '26 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
0.040.04-0.61-0.91
Net Debt / Equity Ratio
-0.79-0.84-0.11-0.59
Net Debt / EBITDA Ratio
0.780.96-0.29-0.86
Net Debt / FCF Ratio
0.720.90-0.38-0.84
Asset Turnover
-0.12--
Quick Ratio
9.0810.780.350.56
Current Ratio
9.6211.380.350.58
Return on Assets (ROA)
--47.87%-52.88%-
Return on Capital Employed (ROCE)
-100.40%-86.20%47.20%888.20%
Buyback Yield / Dilution
--16.65%-6.69%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.